Skip to content

Clinical trials

Withdrawn Phase 2 Lymphoma, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Phase: Phase 2 Status: Withdrawn Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20181
20201
20211
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
Academic and Community Cancer Research United1
The First Affiliated Hospital of Soochow University1
The Methodist Hospital Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell7
Burkitt Lymphoma3
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Mantle-Cell2
Lymphoma, T-Cell2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Hematologic Neoplasms1
Leukemia, Biphenotypic, Acute1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.